Fundacion Instituto de Reumatologia Fernando Chalem

Recent papers from Fundacion Instituto de Reumatologia Fernando Chalem

1. NeuroPORTRESS: prevalence, clinical spectrum, and factors associated with neurological involvement in Sjögren’s diseaseFrontiers in Immunology · 2026
2. Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohortFrontiers in Medicine · 2026
3. Innovative diagnostic techniques and their clinical implications in food allergy: current clinical practice and future perspectivesFrontiers in Allergy · 2026
4. From Invisible to Visible: Cutting-Edge Ultrasound Insights into Entheses of the Distal Extremities in RheumatologyJournal of Clinical Medicine · 2026
5. Ultrasound assessment of vertebral ligaments: development and validation of a landmark-based scanning protocol with potential applicability in spondyloarthritisRMD Open · 2026
6. Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin AmericaInternational Journal of Rheumatic Diseases · 2026
7. Frequency and associated factors of herpes zoster infection in SLE patients from Latin America: data from the GLADEL 2.0 cohortLupus Science & Medicine · 2026
8. Filum disease behind fibromyalgia: A preliminary studyJournal of the Neurological Sciences · 2025
9. Successful treatment association of interleukin-1 inhibitor anakinra and Janus kinase inhibitor baricitinib in Still’s diseaseScandinavian Journal of Rheumatology · 2026
10. Advances in Measuring the Biodegradability of a Hybrid Material Resulting from the Transformation of Plastic and Organic Waste with the Oyster Culinary-Medicinal Mushroom Pleurotus ostreatus (Agaricomycetes)International journal of medicinal mushrooms · 2026
11. Gut expression of CD71 and co-localisation with Dec-1 associated with high levels of serum SIgA and disease activity in SpAScientific Reports · 2025
12. Rheumatoid arthritis-associated interstitial lung disease in countries across the worldSeminars in Arthritis and Rheumatism · 2025
13. Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 studyExpert Review of Clinical Immunology · 2025
14. Elevated Calprotectin Levels Reveal Loss of Vascular Pattern and Atrophy of Villi in Ileum by Digital Chromoendoscopy and Magnification Colonoscopy in Patients with Spondyloarthritis Without Having Inflammatory Bowel DiseaseDiagnostics · 2024
15. Ab1617-HPR Assessing the Impact of a Multidisciplinary Care Model on an Established Cohort of Rheumatoid Arthritis Patients in Colombia – A Ten-Year Real-Life Cohort ExperienceAnnals of the Rheumatic Diseases · 2024
16. Ab1581-HPR Description of the Use of Rituximab Off-Label - Experience of a Center Specialized in RheumatologyAnnals of the Rheumatic Diseases · 2024
17. OP0267 REVERSE TRANSCYTOSIS IN ILEUM IS A MECHANISM WHICH COULD EXPLAIN THE HIGH LEVELS OF SERUM SECRETORY IgA IN SpA PATIENTSAnnals of the Rheumatic Diseases · 2024
18. P127 Comparison of the Efficacy, Safety and Immunogenicity of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Moderate-to-Severe Rheumatoid Arthritis: Results of a Randomized Double-Blind StudyLara D. Veeken · 2024
19. Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritisClinical Rheumatology · 2024
20. Colonoscopy aspiration lavages for mucosal metataxonomic profiling of spondylarthritis-associated gastrointestinal tract alterationsScientific Reports · 2023